These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 8418298
1. Purification and characterisation of intracellular toxin A of Clostridium difficile. Meng XQ, Kamiya S, Yamakawa K, Ogura H, Nakamura S. J Med Microbiol; 1993 Jan; 38(1):69-73. PubMed ID: 8418298 [Abstract] [Full Text] [Related]
2. A non-haemagglutinating form of Clostridium difficile toxin A. Kamiya S, Borriello SP. J Med Microbiol; 1992 Mar; 36(3):190-7. PubMed ID: 1548692 [Abstract] [Full Text] [Related]
3. Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction. Kamiya S, Reed PJ, Borriello SP. J Med Microbiol; 1989 Sep; 30(1):69-77. PubMed ID: 2778794 [Abstract] [Full Text] [Related]
4. Simplified purification method for Clostridium difficile toxin A. Fu SW, Xue J, Zhang YL, Zhou DY. World J Gastroenterol; 2004 Sep 15; 10(18):2756-8. PubMed ID: 15309736 [Abstract] [Full Text] [Related]
6. Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin. Krivan HC, Wilkins TD. Infect Immun; 1987 Aug 15; 55(8):1873-7. PubMed ID: 3112015 [Abstract] [Full Text] [Related]
7. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related. von Eichel-Streiber C, Harperath U, Bosse D, Hadding U. Microb Pathog; 1987 May 15; 2(5):307-18. PubMed ID: 2467163 [Abstract] [Full Text] [Related]
9. Isolation and purification of Aeromonas sobria cytotonic enterotoxin and beta-haemolysin. Gosling PJ, Turnbull PC, Lightfoot NF, Pether JV, Lewis RJ. J Med Microbiol; 1993 Mar 15; 38(3):227-34. PubMed ID: 8384263 [Abstract] [Full Text] [Related]
10. Comparison of wild type with recombinant Clostridium difficile toxin A. Gerhard R, Burger S, Tatge H, Genth H, Just I, Hofmann F. Microb Pathog; 2005 Mar 15; 38(2-3):77-83. PubMed ID: 15748809 [Abstract] [Full Text] [Related]
13. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A. Torres JF. J Med Microbiol; 1991 Jul 15; 35(1):40-4. PubMed ID: 1906544 [Abstract] [Full Text] [Related]
14. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC). Matsuda M, Ozutsumi K, Du PY, Sugimoto N. Eur J Epidemiol; 1986 Dec 15; 2(4):265-71. PubMed ID: 3542554 [Abstract] [Full Text] [Related]
15. Modification of surface histidine residues abolishes the cytotoxic activity of Clostridium difficile toxin A. Roberts AK, Shone CC. Toxicon; 2001 Dec 15; 39(2-3):325-33. PubMed ID: 10978751 [Abstract] [Full Text] [Related]
16. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Pothoulakis C, Kelly CP, Joshi MA, Gao N, O'Keane CJ, Castagliuolo I, Lamont JT. Gastroenterology; 1993 Apr 15; 104(4):1108-15. PubMed ID: 8462799 [Abstract] [Full Text] [Related]
17. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile. Banno Y, Kobayashi T, Kono H, Watanabe K, Ueno K, Nozawa Y. Rev Infect Dis; 1984 Apr 15; 6 Suppl 1():S11-20. PubMed ID: 6426016 [Abstract] [Full Text] [Related]